Search Results
Prediction of pCR by HRD after Carboplatin Neoadjuvant Chemotherapy in TNBC Patients
What to do in patients with early-stage TNBC who have not achieved a pCR?
No pCR in Patients After Neoadjuvant Chemotherapy in TNBC
Dr. Burris Discusses Recurrence Scores Predicting pCR
Dr. Spring on the Association Between pCR and Neoadjuvant Chemotherapy
Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant Therapy
Dr. Sikov on Bevacizumab or Carboplatin Impact On TNBC Subtype
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer
What is best approach for TNBC patient after achieving pCR
pCR associated with significantly reduced risks of EFS events
Test to identity which breast cancer patients will respond to platinum-based chemotherapy
Pathological complete remission (pCR) of breast cancer following neoadjuvant chemotherapy (NACT)